{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T01:34:56Z","timestamp":1795138496847,"version":"4.10.3"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,11,12]],"date-time":"2022-11-12T00:00:00Z","timestamp":1668211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,12]],"date-time":"2022-11-12T00:00:00Z","timestamp":1668211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81871952"],"award-info":[{"award-number":["81871952"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2023,1,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Metastasis is an important factor contributing to poor prognosis in patients with gastric cancer; yet, the molecular mechanism leading to this cell behavior is still not well understood. In this study, we explored the role of cysteine protease inhibitor SN (Cystatin SN, CST1) in promoting gastric cancer metastasis. We hypothesized that CST1 could regulate gastric cancer progression by regulating GPX4 and ferroptosis. Whole transcriptome sequencing suggested that the expression of CST1 was significantly increased in metastatic cancer, and high CST1 expression was correlated with a worse prognosis. Our data further confirmed that the overexpression of CST1 may significantly promote the migration and invasion of gastric cancer cells in vitro and enhance liver, lung, and peritoneal metastasis of gastric cancer in nude mice. Meanwhile, high expression of CST1 promoted the epithelial-mesenchymal transition (EMT) of gastric cancer cells. Mechanistically, a co-immunoprecipitation experiment combined with mass spectrometry analysis confirmed that CST1 could interact with GPX4, a key protein regulating ferroptosis. CST1 relieves GPX4 ubiquitination modification by recruiting OTUB1, improving GPX4 protein stability and reducing intracellular reactive oxygen species (ROS), thereby inhibiting ferroptosis and, in turn, promoting gastric cancer metastasis. Moreover, clinical data suggested that CST1 is significantly increased in peripheral blood and ascites of gastric cancer patients with metastasis; multivariate Cox regression model analysis showed that CST1 was an independent risk factor for the prognosis of gastric cancer patients. Overall, our results elucidated a critical pathway through which high CST1 expression protects gastric cancer cells from undergoing ferroptosis, thus promoting its progression and metastasis. CST1 may be used as a new oncological marker and potential therapeutic target for gastric cancer metastasis.<\/jats:p>","DOI":"10.1038\/s41388-022-02537-x","type":"journal-article","created":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T22:02:59Z","timestamp":1668204179000},"page":"83-98","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":302,"title":["CST1 inhibits ferroptosis and promotes gastric cancer metastasis by regulating GPX4 protein stability via OTUB1"],"prefix":"10.1038","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2905-9079","authenticated-orcid":false,"given":"Dongbao","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8503-4071","authenticated-orcid":false,"given":"Anqi","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayu","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weikang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gege","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaoyang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhao","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3323-3989","authenticated-orcid":false,"given":"Lei","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8986-3918","authenticated-orcid":false,"given":"Lin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6829-6149","authenticated-orcid":false,"given":"Jin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,12]]},"reference":[{"key":"2537_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"2537_CR2","doi-asserted-by":"publisher","first-page":"175883591986752","DOI":"10.1177\/1758835919867522","volume":"11","author":"EC Smyth","year":"2019","unstructured":"Smyth EC, Moehler M. Late-line treatment in metastatic gastric cancer: today and tomorrow. Ther Adv Med Oncol. 2019;11:1758835919867522.","journal-title":"Ther Adv Med Oncol"},{"key":"2537_CR3","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1042\/bss0700179","volume":"70","author":"M Abrahamson","year":"2003","unstructured":"Abrahamson M, Alvarez-Fernandez M, Nathanson CM. Cystatins. Biochem Soc Symp. 2003;70:179\u201399.","journal-title":"Biochem Soc Symp"},{"key":"2537_CR4","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.archoralbio.2012.12.011","volume":"58","author":"P de Sousa-Pereira","year":"2013","unstructured":"de Sousa-Pereira P, Amado F, Abrantes J, Ferreira R, Esteves PJ, Vitorino R. An evolutionary perspective of mammal salivary peptide families: cystatins, histatins, statherin and PRPs. Arch Oral Biol. 2013;58:451\u20138.","journal-title":"Arch Oral Biol"},{"key":"2537_CR5","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1177\/00220345990780080501","volume":"78","author":"TR Hiltke","year":"1999","unstructured":"Hiltke TR, Lee TC, Bobek LA. Structure\/function analysis of human cystatin SN and comparison of the cysteine proteinase inhibitory profiles of human cystatins C and SN. J Dent Res. 1999;78:1401\u20139.","journal-title":"J Dent Res"},{"key":"2537_CR6","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1006\/abbi.2000.1909","volume":"380","author":"CC Tseng","year":"2000","unstructured":"Tseng CC, Tseng CP, Levine MJ, Bobek LA. Differential effect toward inhibition of papain and cathepsin C by recombinant human salivary cystatin SN and its variants produced by a baculovirus system. Arch Biochem Biophys. 2000;380:133\u201340.","journal-title":"Arch Biochem Biophys"},{"key":"2537_CR7","doi-asserted-by":"publisher","first-page":"3411","DOI":"10.2147\/OTT.S194332","volume":"12","author":"Y Liu","year":"2019","unstructured":"Liu Y, Yao J. Research progress of cystatin SN in cancer. Onco Targets Ther. 2019;12:3411\u20139.","journal-title":"Onco Targets Ther"},{"key":"2537_CR8","doi-asserted-by":"publisher","first-page":"11359","DOI":"10.2147\/OTT.S234328","volume":"12","author":"Y Liu","year":"2019","unstructured":"Liu Y, Ma H, Wang Y, Du X, Yao J. Cystatin SN affects cell proliferation by regulating the ERalpha\/PI3K\/AKT\/ERalpha loopback pathway in breast cancer. Onco Targets Ther. 2019;12:11359\u201369.","journal-title":"Onco Targets Ther"},{"key":"2537_CR9","first-page":"781","volume":"53","author":"J Jiang","year":"2018","unstructured":"Jiang J, Liu HL, Tao L, Lin XY, Yang YD, Tan SW, et al. Let7d inhibits colorectal cancer cell proliferation through the CST1\/p65 pathway. Int J Oncol. 2018;53:781\u201390.","journal-title":"Int J Oncol"},{"key":"2537_CR10","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1007\/s00109-017-1537-1","volume":"95","author":"DN Dai","year":"2017","unstructured":"Dai DN, Li Y, Chen B, Du Y, Li SB, Lu SX, et al. Elevated expression of CST1 promotes breast cancer progression and predicts a poor prognosis. J Mol Med. 2017;95:873\u201386.","journal-title":"J Mol Med"},{"key":"2537_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.485","volume":"4","author":"JT Kim","year":"2013","unstructured":"Kim JT, Lee SJ, Kang MA, Park JE, Kim BY, Yoon DY, et al. Cystatin SN neutralizes the inhibitory effect of cystatin C on cathepsin B activity. Cell Death Dis. 2013;4:e974.","journal-title":"Cell Death Dis"},{"key":"2537_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.100","volume":"8","author":"BM Oh","year":"2017","unstructured":"Oh BM, Lee SJ, Cho HJ, Park YS, Kim JT, Yoon SR, et al. Cystatin SN inhibits auranofin-induced cell death by autophagic induction and ROS regulation via glutathione reductase activity in colorectal cancer. Cell Death Dis. 2017;8:e2682.","journal-title":"Cell Death Dis"},{"key":"2537_CR13","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.cca.2009.05.008","volume":"406","author":"EH Choi","year":"2009","unstructured":"Choi EH, Kim J-T, Kim JH, Kim S-Y, Song EY, Kim JW, et al. Upregulation of the cysteine protease inhibitor, cystatin SN, contributes to cell proliferation and cathepsin inhibition in gastric cancer. Clin Chim Acta. 2009;406:45\u201351.","journal-title":"Clin Chim Acta"},{"key":"2537_CR14","first-page":"202","volume":"42","author":"J Kim","year":"2019","unstructured":"Kim J, Bae DH, Kim JH, Song KS, Kim YS, Kim SY. HOXC10 overexpression promotes cell proliferation and migration in gastric cancer. Oncol Rep. 2019;42:202\u201312.","journal-title":"Oncol Rep"},{"key":"2537_CR15","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.2147\/CMAR.S277770","volume":"13","author":"S Chen","year":"2021","unstructured":"Chen S, Liu Y, Zhang K, Chen L. CST1 promoted gastric cancer migration and invasion through activating Wnt pathway. Cancer Manag Res. 2021;13:1901\u20137.","journal-title":"Cancer Manag Res"},{"key":"2537_CR16","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","volume":"31","author":"D Tang","year":"2021","unstructured":"Tang D, Chen X, Kang R, Kroemer G. Ferroptosis: molecular mechanisms and health implications. Cell Res. 2021;31:107\u201325.","journal-title":"Cell Res"},{"key":"2537_CR17","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 2021;22:266\u201382.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2537_CR18","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41586-020-2623-z","volume":"585","author":"JM Ubellacker","year":"2020","unstructured":"Ubellacker JM, Tasdogan A, Ramesh V, Shen B, Mitchell EC, Martin-Sandoval MS, et al. Lymph protects metastasizing melanoma cells from ferroptosis. Nature. 2020;585:113\u20138.","journal-title":"Nature."},{"key":"2537_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-019-1177-1","volume":"21","author":"A Nagpal","year":"2019","unstructured":"Nagpal A, Redvers RP, Ling X, Ayton S, Fuentes M, Tavancheh E, et al. Neoadjuvant neratinib promotes ferroptosis and inhibits brain metastasis in a novel syngeneic model of spontaneous HER2+ve breast cancer metastasis. Breast Cancer Res. 2019;21:94.","journal-title":"Breast Cancer Res"},{"key":"2537_CR20","doi-asserted-by":"publisher","first-page":"e1800311","DOI":"10.1002\/pmic.201800311","volume":"19","author":"GC Forcina","year":"2019","unstructured":"Forcina GC, Dixon SJ. GPX4 at the crossroads of lipid homeostasis and ferroptosis. Proteomics. 2019;19:e1800311.","journal-title":"Proteomics."},{"key":"2537_CR21","doi-asserted-by":"publisher","first-page":"101060","DOI":"10.1016\/j.redox.2018.11.018","volume":"25","author":"SO Pohl","year":"2019","unstructured":"Pohl SO, Pervaiz S, Dharmarajan A, Agostino M. Gene expression analysis of heat-shock proteins and redox regulators reveals combinatorial prognostic markers in carcinomas of the gastrointestinal tract. Redox Biol. 2019;25:101060.","journal-title":"Redox Biol"},{"key":"2537_CR22","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41571-020-00462-0","volume":"18","author":"X Chen","year":"2021","unstructured":"Chen X, Kang R, Kroemer G, Tang D. Broadening horizons: the role of ferroptosis in cancer. Nat Rev Clin Oncol. 2021;18:280\u201396.","journal-title":"Nat Rev Clin Oncol"},{"key":"2537_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2021.09.014","volume":"522","author":"Y Lu","year":"2021","unstructured":"Lu Y, Qin H, Jiang B, Lu W, Hao J, Cao W, et al. KLF2 inhibits cancer cell migration and invasion by regulating ferroptosis through GPX4 in clear cell renal cell carcinoma. Cancer Lett. 2021;522:1\u201313.","journal-title":"Cancer Lett"},{"key":"2537_CR24","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1007\/s12272-020-01281-8","volume":"43","author":"J Park","year":"2020","unstructured":"Park J, Cho J, Song EJ. Ubiquitin-proteasome system (UPS) as a target for anticancer treatment. Arch Pharm Res. 2020;43:1144\u201361.","journal-title":"Arch Pharm Res"},{"key":"2537_CR25","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1126\/science.aax3769","volume":"366","author":"C Pohl","year":"2019","unstructured":"Pohl C, Dikic I. Cellular quality control by the ubiquitin-proteasome system and autophagy. Science. 2019;366:818\u201322.","journal-title":"Science."},{"key":"2537_CR26","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1038\/s41418-020-00728-1","volume":"28","author":"X Chen","year":"2021","unstructured":"Chen X, Yu C, Kang R, Kroemer G, Tang D. Cellular degradation systems in ferroptosis. Cell Death Differ. 2021;28:1135\u201348.","journal-title":"Cell Death Differ"},{"key":"2537_CR27","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1158\/0008-5472.CAN-18-3037","volume":"79","author":"T Liu","year":"2019","unstructured":"Liu T, Jiang L, Tavana O, Gu W. The deubiquitylase OTUB1 mediates ferroptosis via stabilization of SLC7A11. Cancer Res. 2019;79:1913\u201324.","journal-title":"Cancer Res"},{"key":"2537_CR28","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13045-020-01016-8","volume":"14","author":"Y Ding","year":"2021","unstructured":"Ding Y, Chen X, Liu C, Ge W, Wang Q, Hao X, et al. Identification of a small molecule as inducer of ferroptosis and apoptosis through ubiquitination of GPX4 in triple negative breast cancer cells. J Hematol Oncol. 2021;14:19.","journal-title":"J Hematol Oncol"},{"key":"2537_CR29","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1038\/s41418-020-00700-z","volume":"28","author":"D Zhu","year":"2021","unstructured":"Zhu D, Xu R, Huang X, Tang Z, Tian Y, Zhang J, et al. Deubiquitinating enzyme OTUB1 promotes cancer cell immunosuppression via preventing ER-associated degradation of immune checkpoint protein PD-L1. Cell Death Differ. 2021;28:1773\u201389.","journal-title":"Cell Death Differ"},{"key":"2537_CR30","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.tcb.2020.07.003","volume":"30","author":"B Bakir","year":"2020","unstructured":"Bakir B, Chiarella AM, Pitarresi JR, Rustgi AK. EMT, MET, plasticity, and tumor metastasis. Trends Cell Biol. 2020;30:764\u201376.","journal-title":"Trends Cell Biol"},{"key":"2537_CR31","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1002\/2211-5463.13221","volume":"11","author":"J Ding","year":"2021","unstructured":"Ding J, Wang X, Gao J, Song T. Silencing of cystatin SN abrogates cancer progression and stem cell properties in papillary thyroid carcinoma. FEBS Open Bio. 2021;11:2186\u201397.","journal-title":"FEBS Open Bio"},{"key":"2537_CR32","doi-asserted-by":"publisher","first-page":"22623","DOI":"10.1002\/jcp.28828","volume":"234","author":"Y Cui","year":"2019","unstructured":"Cui Y, Sun D, Song R, Zhang S, Liu X, Wang Y, et al. Upregulation of cystatin SN promotes hepatocellular carcinoma progression and predicts a poor prognosis. J Cell Physiol. 2019;234:22623\u201334.","journal-title":"J Cell Physiol"},{"key":"2537_CR33","doi-asserted-by":"publisher","first-page":"949","DOI":"10.3389\/fonc.2020.00949","volume":"10","author":"L Yang","year":"2020","unstructured":"Yang L, Chen X, Yang Q, Chen J, Huang Q, Yao L, et al. Broad spectrum deubiquitinase inhibition induces both apoptosis and ferroptosis in cancer cells. Front Oncol. 2020;10:949.","journal-title":"Front Oncol"},{"key":"2537_CR34","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.bbrc.2020.07.032","volume":"531","author":"Y Wang","year":"2020","unstructured":"Wang Y, Liu Y, Liu J, Kang R, Tang D. NEDD4L-mediated LTF protein degradation limits ferroptosis. Biochem Biophys Res Commun. 2020;531:581\u20137.","journal-title":"Biochem Biophys Res Commun"},{"key":"2537_CR35","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1126\/science.1230161","volume":"339","author":"A Ernst","year":"2013","unstructured":"Ernst A, Avvakumov G, Tong J, Fan Y, Zhao Y, Alberts P, et al. A strategy for modulation of enzymes in the ubiquitin system. Science. 2013;339:590\u20135.","journal-title":"Science"},{"key":"2537_CR36","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.pharmthera.2014.11.002","volume":"147","author":"P D\u2019Arcy","year":"2015","unstructured":"D\u2019Arcy P, Wang X, Linder S. Deubiquitinase inhibition as a cancer therapeutic strategy. Pharm Ther. 2015;147:32\u201354.","journal-title":"Pharm Ther"},{"key":"2537_CR37","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.cell.2005.11.007","volume":"123","author":"SM Nijman","year":"2005","unstructured":"Nijman SM, Luna-Vargas MP, Velds A, Brummelkamp TR, Dirac AM, Sixma TK, et al. A genomic and functional inventory of deubiquitinating enzymes. Cell. 2005;123:773\u201386.","journal-title":"Cell."},{"key":"2537_CR38","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1530\/ERC-18-0264","volume":"26","author":"M Saldana","year":"2019","unstructured":"Saldana M, VanderVorst K, Berg AL, Lee H, Carraway KL. Otubain 1: a non-canonical deubiquitinase with an emerging role in cancer. Endocr Relat Cancer. 2019;26:R1\u201314.","journal-title":"Endocr Relat Cancer"},{"key":"2537_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-13-258","volume":"13","author":"Y Zhou","year":"2014","unstructured":"Zhou Y, Wu J, Fu X, Du W, Zhou L, Meng X, et al. OTUB1 promotes metastasis and serves as a marker of poor prognosis in colorectal cancer. Mol Cancer. 2014;13:258.","journal-title":"Mol Cancer"},{"key":"2537_CR40","doi-asserted-by":"publisher","first-page":"3356","DOI":"10.1038\/s41388-018-0224-1","volume":"37","author":"H Zhou","year":"2018","unstructured":"Zhou H, Liu Y, Zhu R, Ding F, Cao X, Lin D, et al. OTUB1 promotes esophageal squamous cell carcinoma metastasis through modulating Snail stability. Oncogene. 2018;37:3356\u201368.","journal-title":"Oncogene."},{"key":"2537_CR41","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ccell.2020.06.001","volume":"38","author":"JD Hayes","year":"2020","unstructured":"Hayes JD, Dinkova-Kostova AT, Tew KD. Oxidative stress in cancer. Cancer Cell. 2020;38:167\u201397.","journal-title":"Cancer Cell"},{"key":"2537_CR42","doi-asserted-by":"publisher","first-page":"151073","DOI":"10.1016\/j.ejcb.2020.151073","volume":"99","author":"R Chatterjee","year":"2020","unstructured":"Chatterjee R, Chatterjee J. ROS and oncogenesis with special reference to EMT and stemness. Eur J Cell Biol. 2020;99:151073.","journal-title":"Eur J Cell Biol"},{"key":"2537_CR43","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41586-019-1426-6","volume":"572","author":"J Wu","year":"2019","unstructured":"Wu J, Minikes AM, Gao M, Bian H, Li Y, Stockwell BR, et al. Intercellular interaction dictates cancer cell ferroptosis via NF2-YAP signalling. Nature. 2019;572:402\u20136.","journal-title":"Nature."}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-022-02537-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-022-02537-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-022-02537-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,8]],"date-time":"2023-01-08T23:11:08Z","timestamp":1673219468000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-022-02537-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,12]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,1,5]]}},"alternative-id":["2537"],"URL":"https:\/\/doi.org\/10.1038\/s41388-022-02537-x","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,12]]},"assertion":[{"value":"29 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All study participants provided informed consent, and the study design was approved by Institutional Ethics Committee of the First Affiliated Hospital of Soochow University approved this study (approval number: 2020381). All authors consent to the publication of the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}